BALA CYNWYD, Pa., Nov. 7, 2013 /PRNewswire/ -- Law Office of Brodsky & Smith, LLC announces that a class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of all those investors who purchased or otherwise acquired shares of Edwards Lifesciences Corporation, Inc. (NYSE: EW) ("Edwards Lifesciences" or the "Company") between April 25, 2012 and April 23, 2013, inclusive (the "Class Period").
Click here to learn more http://brodsky-smith.com/673-ew-edwards-lifesciences-corporation.html, or call: 877-534-2590. There is no cost or obligation to you.
The Complaint alleges that the defendants made materially false and misleading statements, including failing to disclose that adoption of SAPIEN was weaker than the Company claimed, the Company's outlook for sales and earnings per share was weaker than suggested to investors, and the Company lacked a reasonable basis for its statements relating to the Company's operations, forecasts, and outlook.
If you are a member of the class described above, you may, not later than November 18, 2013, to move the Court to serve as a lead plaintiff of the class, if you so choose. If you purchased shares of Edwards Lifesciences stock during the Class Period and wish to discuss this action, you may e-mail or call the Law Office of Brodsky & Smith, LLC who will, without obligation or cost to you, answer your questions. Please contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, e-mail at email@example.com, by visiting http://brodsky-smith.com/673-ew-edwards-lifesciences-corporation.html, or calling toll free 877-LEGAL-90.Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV